Patents by Inventor John Dixon

John Dixon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS, COMPOSITIONS AND USES RELATING THERETO
    Publication number: 20190091121
    Abstract: A method of combatting colour loss from a dyed material, the method comprising contacting the material with a composition comprising an alpha-substituted aldehyde.
    Type: Application
    Filed: April 21, 2017
    Publication date: March 28, 2019
    Applicant: Innospec Limited
    Inventors: Nicholas John Dixon, Matthew Robert Giles, Kimberley Elizabeth Griffiths, Tony Gough, Ian Malcolm McRobbie
  • METHODS, COMPOSITIONS AND USES RELATING THERETO
    Publication number: 20190091120
    Abstract: A method of treating a material, the method comprising contacting the material with a composition comprising an alpha-substituted aldehyde.
    Type: Application
    Filed: April 21, 2017
    Publication date: March 28, 2019
    Applicant: Innospec Limited
    Inventors: Tony Gough, Matthew Robert Giles, Kimberley Elizabeth Griffiths, Nicholas John Dixon, Ian Malcolm McRobbie
  • METHODS, COMPOSITIONS AND USES RELATING THERETO
    Publication number: 20190091119
    Abstract: A method of combating colour loss from a dyed material, the method comprising contacting the material with a composition comprising a hydroxy-substituted aldehyde.
    Type: Application
    Filed: April 21, 2017
    Publication date: March 28, 2019
    Applicant: INNOSPEC LIMITED
    Inventors: Nicholas John DIXON, Matthew Robert GILES, Kimberley Elizabeth GRIFFITHS, Tony GOUGH, Ian Malcolm MCROBBIE
  • METHODS, COMPOSITIONS AND USES RELATING THERETO
    Publication number: 20190083375
    Abstract: A method of treating a material, the method comprising contacting the material with a composition comprising a hydroxy-substituted aldehyde.
    Type: Application
    Filed: April 21, 2017
    Publication date: March 21, 2019
    Applicant: INNOSPEC LIMITED
    Inventors: Tony GOUGH, Matthew Robert GILES, Kimberley Elizabeth GRIFFITHS, Nicholas John DIXON, Ian Malcolm MCROBBIE
  • Antibody therapeutics that bind CD137
    Patent number: 10233251
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD137 antibodies. More specifically, there is disclosed fully human antibodies that bind CD137, CD137-antibody binding fragments and derivatives of such antibodies, and CD137-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease requiring either stimulation of immune responses or suppression. Diseases amenable to treatment is selected from the group consisting of cancers, autoimmune diseases and viral infections.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: March 19, 2019
    Assignee: Sorrento Therapeutics, Inc.
    Inventors: John Dixon Gray, Heyue Zhou
  • Antigen Binding Proteins that Bind CCR2
    Publication number: 20190062440
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CCR2 antibodies. More specifically, there is disclosed fully human antibodies that bind CCR2, CCR2-binding fragments and derivatives of such antibodies, and CCR2-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having CCR2 related disorders or conditions.
    Type: Application
    Filed: March 19, 2018
    Publication date: February 28, 2019
    Inventors: Dingqiu Huang, Barbara A. Swanson, John Dixon Gray, Heyue Zhou, Guodi Lu
  • ANTIGEN BINDING PROTEINS THAT BIND PD-L1
    Publication number: 20190060451
    Abstract: There is disclosed compositions and methods relating to or derived from anti-PD-L1 antibodies. More specifically, there is disclosed fully human antibodies that bind PD-L1, PD-L1-binding fragments and derivatives of such antibodies, and PD-L1-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having PD-L1 related disorders or conditions, including various inflammatory disorders and various cancers.
    Type: Application
    Filed: August 24, 2018
    Publication date: February 28, 2019
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: Heyue Zhou, Randy Gastwirt, Barbara A. Swanson, John Dixon Gray, Gunnar F. Kaufmann
  • Fully Human Antibodies that Bind to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
    Publication number: 20190048087
    Abstract: There is disclosed compositions and methods relating to anti-VEGFR2 antibodies. More specifically, there is disclosed fully human antibodies that bind VEGFR2, VEGFR2-binding fragments and derivatives of such antibodies, and VEGFR2-binding polypeptides comprising such fragments. Further still, there is disclosed antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having various cancers.
    Type: Application
    Filed: April 7, 2015
    Publication date: February 14, 2019
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: Randy Gastwirt, Heyue Zhou, John Dixon Gray, Guodi Lu
  • ANTIBODY THERAPEUTICS THAT BIND CD38
    Publication number: 20190048092
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD38 antibodies. More specifically, there is disclosed fully human antibodies that bind CD38, CD38-antibody binding fragments and derivatives of such antibodies, and CD38-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease.
    Type: Application
    Filed: August 4, 2018
    Publication date: February 14, 2019
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: Heyue Zhou, John Dixon Gray
  • Antibody therapeutics that bind CTLA4
    Patent number: 10202453
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CTLA4 antibodies. More specifically, there is disclosed fully human antibodies that bind CTLA4, CTLA4-antibody binding fragments and derivatives of such antibodies, and CTLA4-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease requiring either stimulation of immune responses or suppression.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: February 12, 2019
    Assignee: Sorrento Therapeutics, Inc.
    Inventors: John Dixon Gray, Heyue Zhou
  • THERMALLY INKJETTABLE ACRYLIC DIELECTRIC INK FORMULATION AND PROCESS
    Publication number: 20190023914
    Abstract: An aqueous composition for forming a micro-fluid jet printable dielectric film layer, methods for forming dielectric film layers, and dielectric film layers formed by the method. The aqueous composition includes from about 5 to about 20 percent by 65 weight of a polymeric binder emulsion, from about 10 to about 30 percent by weight of a humectant, from about 0 to about 3 percent by weight of a surfactant, and an aqueous carrier fluid. The aqueous composition has a viscosity ranging from about 2 to about 6 centipoise at a temperature of about 23° C.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 24, 2019
    Applicant: FUNAI ELECTRIC CO., LTD.
    Inventors: Xiaorong Cai, Michael John Dixon, Yimin Guan, Ann P. Holloway, Jeanne Marie Saldanha Singh, Zhigang Xiao
  • ANTIBODY THERAPEUTICS THAT BIND CD123
    Publication number: 20190002576
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD123 antibodies. More specifically, there is disclosed fully human antibodies that bind CD123, CD123-antibody binding fragments and derivatives of such antibodies, and CD123-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease.
    Type: Application
    Filed: September 19, 2018
    Publication date: January 3, 2019
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: Heyue Zhou, John Dixon Gray
  • Managing access rights to content using social media
    Patent number: 10127326
    Abstract: Provided are methods and systems related to communications between a social media service or provider (e.g., Twitter®, Facebook®) or other resource (e.g., web page) and one or more content providers. In an aspect, provided are methods comprising receiving a request for content, wherein the request comprises a user agnostic identifier, determining user information associated with the request, determining time information associated with the request, determining media content associated with the user agnostic identifier based on the time information, determining one or more access rights to the media content based on the user information, and providing access to the media content based on the one or more access rights.
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: November 13, 2018
    Assignee: Comcast Cable Communications Management, LLC
    Inventors: Christian Petersen, Adam Hertz, John Dixon, Sam Schwartz, Preston Smalley
  • Thermally inkjettable acrylic dielectric ink formulation and process
    Patent number: 10113074
    Abstract: An aqueous composition for forming a micro-fluid jet printable dielectric film layer, methods for forming dielectric film layers, and dielectric film layers formed by the method. The aqueous composition includes from about 5 to about 20 percent by 65 weight of a polymeric binder emulsion, from about 10 to about 30 percent by weight of a humectant, from about 0 to about 3 percent by weight of a surfactant, and an aqueous carrier fluid. The aqueous composition has a viscosity ranging from about 2 to about 6 centipoise at a temperature of about 23° C.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: October 30, 2018
    Assignee: FUNAI ELECTRIC CO., LTD.
    Inventors: Xiaorong Cai, Michael John Dixon, Yimin Guan, Ann P. Holloway, Jeanne Marie Saldanha Singh, Zhigang Xiao
  • Antibody therapeutics that bind CD123
    Patent number: 10100118
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD123 antibodies. More specifically, there is disclosed fully human antibodies that bind CD123, CD123-antibody binding fragments and derivatives of such antibodies, and CD123-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: October 16, 2018
    Assignee: Sorrento Therapeutics, Inc.
    Inventors: Heyue Zhou, John Dixon Gray
  • ANTIBODY THERAPEUTICS THAT BIND TIM3
    Publication number: 20180251549
    Abstract: There is disclosed compositions and methods relating to or derived from anti-TIM3 antibodies. More specifically, there is disclosed fully human antibodies that bind TIM3, TIM3-antibody binding fragments and derivatives of such antibodies, and TIM3-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease.
    Type: Application
    Filed: December 14, 2017
    Publication date: September 6, 2018
    Applicant: Sorrento Therapeutics, Inc.
    Inventors: John Dixon Gray, Heyue Zhou, Irina Krapf
  • Antibody therapeutics that bind CD38
    Patent number: 10059774
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD38 antibodies. More specifically, there is disclosed fully human antibodies that bind CD38, CD38-antibody binding fragments and derivatives of such antibodies, and CD38-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: August 28, 2018
    Assignee: Sorrento Therapeutics, Inc.
    Inventors: Heyue Zhou, John Dixon Gray
  • Antigen binding proteins that bind PD-L1
    Patent number: 10058609
    Abstract: There is disclosed compositions and methods relating to or derived from anti-PD-L1 antibodies. More specifically, there is disclosed fully human antibodies that bind PD-L1, PD-L1-binding fragments and derivatives of such antibodies, and PD-L1-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having PD-L1 related disorders or conditions, including various inflammatory disorders and various cancers.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: August 28, 2018
    Assignee: Sorrento Therapeutics, Inc.
    Inventors: Heyue Zhou, Randy Gastwirt, Barbara A. Swanson, John Dixon Gray, Gunnar F. Kaufmann
  • Antibody therapeutics that bind CD47
    Patent number: 10035855
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD47 antibodies. More specifically, there is disclosed fully human antibodies that bind CD47, CD47-antibody binding fragments and derivatives of such antibodies, and CD47-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: July 31, 2018
    Assignee: SORRENTO THERAPEUTICS, INC.
    Inventors: Barbara A. Swanson, John Dixon Gray, Heyue Zhou
  • Antibody therapeutics that bind CD123
    Patent number: 9969807
    Abstract: There is disclosed compositions and methods relating to or derived from anti-CD123 antibodies. More specifically, there is disclosed fully human antibodies that bind CD123, CD123-antibody binding fragments and derivatives of such antibodies, and CD123-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating a disease.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: May 15, 2018
    Assignee: Sorrento Therapeutics, Inc.
    Inventors: John Dixon Gray, Heyue Zhou